BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19937140)

  • 1. Twist2 regulates CD7 expression and galectin-1-induced apoptosis in mature T-cells.
    Koh HS; Lee C; Lee KS; Park EJ; Seong RH; Hong S; Jeon SH
    Mol Cells; 2009 Dec; 28(6):553-8. PubMed ID: 19937140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD7 expression and galectin-1-induced apoptosis of immature thymocytes are directly regulated by NF-kappaB upon T-cell activation.
    Koh HS; Lee C; Lee KS; Ham CS; Seong RH; Kim SS; Jeon SH
    Biochem Biophys Res Commun; 2008 May; 370(1):149-53. PubMed ID: 18355446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-1-mediated apoptosis in mycosis fungoides: the roles of CD7 and cell surface glycosylation.
    Roberts AA; Amano M; Felten C; Galvan M; Sulur G; Pinter-Brown L; Dobbeling U; Burg G; Said J; Baum LG
    Mod Pathol; 2003 Jun; 16(6):543-51. PubMed ID: 12808059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+CD7- leukemic T cells from patients with Sézary syndrome are protected from galectin-1-triggered T cell death.
    Rappl G; Abken H; Muche JM; Sterry W; Tilgen W; André S; Kaltner H; Ugurel S; Gabius HJ; Reinhold U
    Leukemia; 2002 May; 16(5):840-5. PubMed ID: 11986945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysfunctional immunoregulation in human liver allograft rejection associated with compromised galectin-1/CD7 pathway function.
    Wei S; Cao D; Liu Z; Li J; Wu H; Gong J; Liu Y; Wu Y
    Cell Death Dis; 2018 Feb; 9(3):293. PubMed ID: 29463785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1.
    Pace KE; Lee C; Stewart PL; Baum LG
    J Immunol; 1999 Oct; 163(7):3801-11. PubMed ID: 10490978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis.
    Fukumori T; Takenaka Y; Yoshii T; Kim HR; Hogan V; Inohara H; Kagawa S; Raz A
    Cancer Res; 2003 Dec; 63(23):8302-11. PubMed ID: 14678989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7.
    Bremer E; Samplonius DF; Peipp M; van Genne L; Kroesen BJ; Fey GH; Gramatzki M; de Leij LF; Helfrich W
    Cancer Res; 2005 Apr; 65(8):3380-8. PubMed ID: 15833872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7- T lymphocyte subsets in Sézary syndrome.
    Dummer R; Nestle FO; Niederer E; Ludwig E; Laine E; Grundmann H; Grob P; Burg G
    Arch Dermatol Res; 1999 Jun; 291(6):307-11. PubMed ID: 10421055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Twist2 is controlled by T-cell receptor signaling and determines the survival and death of thymocytes.
    Oh S; Oh J; Lee C; Oh S; Jeon S; Choi J; Hwang S; Lee Y; Lee H; Seong RH
    Cell Death Differ; 2016 Nov; 23(11):1804-1814. PubMed ID: 27391798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome).
    Vonderheid EC; Bigler RD; Kotecha A; Boselli CM; Lessin SR; Bernengo MG; Polansky M
    J Invest Dermatol; 2001 Sep; 117(3):654-62. PubMed ID: 11564173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of thymocyte development and cytokine production in CD7-deficient, CD28-deficient and CD7/CD28 double-deficient mice.
    Heinly CS; Sempowski GD; Lee DM; Patel DD; McDermott PM; Scearce RM; Thompson CB; Haynes BF
    Int Immunol; 2001 Feb; 13(2):157-66. PubMed ID: 11157849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death.
    Pace KE; Hahn HP; Pang M; Nguyen JT; Baum LG
    J Immunol; 2000 Sep; 165(5):2331-4. PubMed ID: 10946254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KLF15-activating Twist2 ameliorated hepatic steatosis by inhibiting inflammation and improving mitochondrial dysfunction
    Zhou L; Li Q; Chen A; Liu N; Chen N; Chen X; Zhu L; Xia B; Gong Y; Chen X
    FASEB J; 2019 Dec; 33(12):14254-14269. PubMed ID: 31648561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skewed expression of activation, differentiation and homing-related antigens in circulating cells from patients with cutaneous T cell lymphoma associated with CD7- T helper lymphocytes expansion.
    Scala E; Russo G; Cadoni S; Narducci MG; Girardelli CR; De Pità O; Puddu P
    J Invest Dermatol; 1999 Oct; 113(4):622-7. PubMed ID: 10504451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TWIST2 inhibits EMT and induces oxidative stress in lung cancer cells by regulating the FGF21-mediated AMPK/mTOR pathway.
    Song Y; Zhang W; Zhang J; You Z; Hu T; Shao G; Zhang Z; Xu Z; Yu X
    Exp Cell Res; 2021 Aug; 405(1):112661. PubMed ID: 34044016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of genetically defined tumor cells in CD7 as well as CD26 positive and negative circulating T-cell subsets in Sézary syndrome.
    Steinhoff M; Schöpp S; Assaf C; Muche M; Beyer M; Sterry W; Lukowsky A
    Leuk Res; 2009 Jan; 33(1):88-99. PubMed ID: 18672285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation.
    Sturm A; Lensch M; André S; Kaltner H; Wiedenmann B; Rosewicz S; Dignass AU; Gabius HJ
    J Immunol; 2004 Sep; 173(6):3825-37. PubMed ID: 15356130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TWIST2-mediated chromatin remodeling promotes fusion-negative rhabdomyosarcoma.
    Shah AM; Guo L; Morales MG; Jaichander P; Chen K; Huang H; Cano Hernandez K; Xu L; Bassel-Duby R; Olson EN; Liu N
    Sci Adv; 2023 Apr; 9(17):eade8184. PubMed ID: 37115930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twist2 amplification in rhabdomyosarcoma represses myogenesis and promotes oncogenesis by redirecting MyoD DNA binding.
    Li S; Chen K; Zhang Y; Barnes SD; Jaichander P; Zheng Y; Hassan M; Malladi VS; Skapek SX; Xu L; Bassel-Duby R; Olson EN; Liu N
    Genes Dev; 2019 Jun; 33(11-12):626-640. PubMed ID: 30975722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.